Modulation oi VP-16 cytotoxicity by carboplatin and 41.8 degrees C hyperthermia

Citation
Dm. Katschinski et al., Modulation oi VP-16 cytotoxicity by carboplatin and 41.8 degrees C hyperthermia, J CANC RES, 127(7), 2001, pp. 425-432
Citations number
30
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
ISSN journal
01715216 → ACNP
Volume
127
Issue
7
Year of publication
2001
Pages
425 - 432
Database
ISI
SICI code
0171-5216(200107)127:7<425:MOVCBC>2.0.ZU;2-F
Abstract
Purpose: To study in vitro the effect of carboplatin and/or hyperthermia in relation to etoposide (VP-16) cytotoxicity in L929 cells. Methodology/resu lts: Cell survival assays demonstrated that the addition of 41.8 degreesC ( x60 min) hyperthermia and carboplatin to VP-16 produced an antagonistic eff ect relative to VP-16 cytotoxicity in L929 cells; administering carboplatin and hyperthermia 24 h before VP-16 reduced this drug resistance; administe ring carboplatin and hyperthermia 48 h before VP-16, however, produced a su pra-additive cytotoxicity. In order to gain insight into the molecular basi s for these observations, we investigated the effect of hyperthermia and/or carboplatin on the stress protein GRP78, which is known to affect VP-16 cy totoxicity. Results obtained were consistent with the hypothesis that carbo platin and hyperthermia perturbation of NAD(+) pools results in down-regula tion of GRP78 with subsequent modulation of VP-16 cytotoxicity. To further explicate these results we studied G-361 as a control cell line that had si gnificantly higher pretreatment NAD(+) levels, which were not affected by c arboplatin and/or hyperthermia. This cell line did not exhibit a down-regul ation of GRP78 or modulation of VP-16 cytotoxicity as a function of carbopl atin and hyperthermia. Conclusions: These data taken collectively, demonstr ate a sequence effect (regarding the aforementioned antineoplastic agents), and provide a framework for future studies directed at the therapeutic opt imization of the sequential application of carboplatin, hyperthermia, and V P-16.